Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Engineered T Cells industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Redmile Group
Pfizer
Bellicum Pharmaceuticals
Elli Lilly and Company
Cells Medica
Gilead Sciences
Unum Therapeutics
Seeking Alpha
Juno Therapeutics
Oxford Biomedica
Novartis
Precision Bioscience
Autolus Limited
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
Application:
Hospitals
Cancer Research Centers
Clinics
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Engineered T Cells Industry Overview
-
1.1.1 Engineered T Cells Market Scope and Market Segments
-
1.1.2 Engineered T Cells Industry Characteristics
-
1.1.3 Global and China Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Engineered T Cells Production Value and Growth Rate (2017-2028)
-
1.2 Global Engineered T Cells Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Tumor Infiltrating Lymphocytes
-
1.2.2 T Cell Receptor {TCR}
-
1.2.3 Chimeric Antigen Receptor (CAR)
-
1.3 Global Engineered T Cells Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals
-
1.3.2 Cancer Research Centers
-
1.3.3 Clinics
-
1.4 Market Analysis by Region
-
1.4.1 North America Engineered T Cells Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Engineered T Cells Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Engineered T Cells Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Engineered T Cells Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Engineered T Cells Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Engineered T Cells Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Engineered T Cells Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Engineered T Cells Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Engineered T Cells Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Engineered T Cells Industry Porter's Five Forces Model Analysis
-
2.2.3 Engineered T Cells Industry PEST Analysis
-
2.3 Engineered T Cells Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Engineered T Cells Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Engineered T Cells Industry
Chapter 3 Global and China Engineered T Cells Market, by Manufacturer
-
3.1 Global and China Engineered T Cells Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Engineered T Cells Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Engineered T Cells Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Engineered T Cells Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Engineered T Cells Market Top 3 Players
Chapter 4 Global and China Engineered T Cells Market, by Type (2017-2028)
-
4.1 Engineered T Cells Market Trend, by Type
-
4.2 Global Engineered T Cells Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Engineered T Cells Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Engineered T Cells Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Engineered T Cells Price Trend, by Type (2017-2028)
-
4.3 China Engineered T Cells Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Engineered T Cells Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Engineered T Cells Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Engineered T Cells Price Trend, by Type (2017-2028)
Chapter 5 Global and China Engineered T Cells Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Engineered T Cells Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Engineered T Cells Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Engineered T Cells Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Engineered T Cells Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Engineered T Cells Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Engineered T Cells Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Engineered T Cells Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Engineered T Cells Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Engineered T Cells Market Analysis
-
7.1 North America Engineered T Cells Market, by Type
-
7.2 North America Engineered T Cells Market, by Application
-
7.3 North America Engineered T Cells Market Analysis and Forecast, by Country
-
7.3.1 United States Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Engineered T Cells Market Analysis
-
8.1 Europe Engineered T Cells Market, by Type
-
8.2 Europe Engineered T Cells Market, by Application
-
8.3 Europe Engineered T Cells Market Analysis and Forecast, by Country
-
8.3.1 Germany Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Engineered T Cells Market Analysis
-
9.1 APAC Engineered T Cells Market, by Type
-
9.2 APAC Engineered T Cells Market, by Application
-
9.3 APAC Engineered T Cells Market Analysis and Forecast, by Country
-
9.3.1 China Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Engineered T Cells Market Analysis
-
10.1 Latin America, Middle East and Africa Engineered T Cells Market, by Type
-
10.2 Latin America, Middle East and Africa Engineered T Cells Market, by Application
-
10.3 Latin America, Middle East and Africa Engineered T Cells Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Engineered T Cells Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Engineered T Cells Company Profiles
-
11.1 Redmile Group
-
11.1.1 Redmile Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Redmile Group Engineered T Cells Product Profiles, Application and Specification
-
11.1.3 Redmile Group Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Pfizer
-
11.2.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Pfizer Engineered T Cells Product Profiles, Application and Specification
-
11.2.3 Pfizer Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Bellicum Pharmaceuticals
-
11.3.1 Bellicum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Bellicum Pharmaceuticals Engineered T Cells Product Profiles, Application and Specification
-
11.3.3 Bellicum Pharmaceuticals Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Elli Lilly and Company
-
11.4.1 Elli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Elli Lilly and Company Engineered T Cells Product Profiles, Application and Specification
-
11.4.3 Elli Lilly and Company Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Cells Medica
-
11.5.1 Cells Medica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Cells Medica Engineered T Cells Product Profiles, Application and Specification
-
11.5.3 Cells Medica Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Gilead Sciences
-
11.6.1 Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Gilead Sciences Engineered T Cells Product Profiles, Application and Specification
-
11.6.3 Gilead Sciences Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Unum Therapeutics
-
11.7.1 Unum Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Unum Therapeutics Engineered T Cells Product Profiles, Application and Specification
-
11.7.3 Unum Therapeutics Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Seeking Alpha
-
11.8.1 Seeking Alpha Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Seeking Alpha Engineered T Cells Product Profiles, Application and Specification
-
11.8.3 Seeking Alpha Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Juno Therapeutics
-
11.9.1 Juno Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Juno Therapeutics Engineered T Cells Product Profiles, Application and Specification
-
11.9.3 Juno Therapeutics Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Oxford Biomedica
-
11.10.1 Oxford Biomedica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Oxford Biomedica Engineered T Cells Product Profiles, Application and Specification
-
11.10.3 Oxford Biomedica Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Novartis
-
11.11.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Novartis Engineered T Cells Product Profiles, Application and Specification
-
11.11.3 Novartis Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Precision Bioscience
-
11.12.1 Precision Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Precision Bioscience Engineered T Cells Product Profiles, Application and Specification
-
11.12.3 Precision Bioscience Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Autolus Limited
-
11.13.1 Autolus Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Autolus Limited Engineered T Cells Product Profiles, Application and Specification
-
11.13.3 Autolus Limited Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Engineered T Cells Industry Investment Prospect and Risk Assessment
-
12.1 Engineered T Cells Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Engineered T Cells Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure China Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Global Engineered T Cells Production Value and Growth Rate (2017-2028)
-
Figure China Engineered T Cells Production Value and Growth Rate (2017-2028)
-
Figure Global Engineered T Cells Market Size and Growth Rate of Tumor Infiltrating Lymphocytes (2017-2028)
-
Figure Global Engineered T Cells Market Size and Growth Rate of T Cell Receptor {TCR} (2017-2028)
-
Figure Global Engineered T Cells Market Size and Growth Rate of Chimeric Antigen Receptor (CAR) (2017-2028)
-
Figure Global Engineered T Cells Market Size and Growth Rate of Hospitals (2017-2028)
-
Figure Global Engineered T Cells Market Size and Growth Rate of Cancer Research Centers (2017-2028)
-
Figure Global Engineered T Cells Market Size and Growth Rate of Clinics (2017-2028)
-
Figure North America Engineered T Cells Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Engineered T Cells Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Engineered T Cells Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Engineered T Cells Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Engineered T Cells Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Engineered T Cells Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Engineered T Cells Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Engineered T Cells Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Engineered T Cells Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Engineered T Cells Market Share, by Manufacturer in 2021
-
Figure Global and China Engineered T Cells Market Share, by Manufacturer in 2022
-
Table Global Engineered T Cells Sales Volume, by Type (2017-2028)
-
Table Global Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Figure Global Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Table Global Engineered T Cells Sales Value, by Type (2017-2028)
-
Table Global Engineered T Cells Sales Value Share, by Type (2017-2028)
-
Figure Global Engineered T Cells Price Trend, by Type (2017-2028)
-
Table China Engineered T Cells Sales Volume, by Type (2017-2028)
-
Table China Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Figure China Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Table China Engineered T Cells Sales Value, by Type (2017-2028)
-
Table China Engineered T Cells Sales Value Share, by Type (2017-2028)
-
Figure China Engineered T Cells Price Trend, by Type (2017-2028)
-
Table Global Engineered T Cells Sales Volume, by Application (2017-2028)
-
Table Global Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure Global Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Table Global Engineered T Cells Sales Value, by Application (2017-2028)
-
Table Global Engineered T Cells Sales Value Share, by Application (2017-2028)
-
Figure Global Engineered T Cells Sales Value Share, by Application (2017-2028)
-
Table China Engineered T Cells Sales Volume, by Application (2017-2028)
-
Table China Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure China Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Table China Engineered T Cells Sales Value, by Application (2017-2028)
-
Table China Engineered T Cells Sales Value Share, by Application (2017-2028)
-
Figure China Engineered T Cells Sales Value Share, by Application (2017-2028)
-
Figure China Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
Figure North America Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Engineered T Cells Production, Import, Consumption and Export (2017-2022)
-
Table North America Engineered T Cells Sales Volume, by Type (2017-2028)
-
Table North America Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Figure North America Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Table North America Engineered T Cells Sales Volume, by Application (2017-2028)
-
Table North America Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure North America Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure United States Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure United States Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Canada Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Table Europe Engineered T Cells Sales Volume, by Type (2017-2028)
-
Table Europe Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Figure Europe Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Table Europe Engineered T Cells Sales Volume, by Application (2017-2028)
-
Table Europe Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure Europe Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure Germany Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure UK Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure UK Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure France Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure France Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Italy Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Spain Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Poland Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Russia Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Table APAC Engineered T Cells Sales Volume, by Type (2017-2028)
-
Table APAC Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Figure APAC Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Table APAC Engineered T Cells Sales Volume, by Application (2017-2028)
-
Table APAC Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure APAC Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure China Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure China Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Japan Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure India Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure India Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Engineered T Cells Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Engineered T Cells Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Engineered T Cells Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Engineered T Cells Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Engineered T Cells Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Engineered T Cells Sales Value and Growth Rate (2017-2028)
-
Table Redmile Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Redmile Group Product Profiles, Application and Specification
-
Table Redmile Group Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bellicum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bellicum Pharmaceuticals Product Profiles, Application and Specification
-
Table Bellicum Pharmaceuticals Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Elli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Elli Lilly and Company Product Profiles, Application and Specification
-
Table Elli Lilly and Company Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cells Medica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cells Medica Product Profiles, Application and Specification
-
Table Cells Medica Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gilead Sciences Product Profiles, Application and Specification
-
Table Gilead Sciences Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Unum Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Unum Therapeutics Product Profiles, Application and Specification
-
Table Unum Therapeutics Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Seeking Alpha Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Seeking Alpha Product Profiles, Application and Specification
-
Table Seeking Alpha Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Juno Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Juno Therapeutics Product Profiles, Application and Specification
-
Table Juno Therapeutics Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Oxford Biomedica Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oxford Biomedica Product Profiles, Application and Specification
-
Table Oxford Biomedica Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Precision Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Precision Bioscience Product Profiles, Application and Specification
-
Table Precision Bioscience Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Autolus Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Autolus Limited Product Profiles, Application and Specification
-
Table Autolus Limited Engineered T Cells Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
